Comments on: Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for JS110 (XPO1 inhibitor)

Comments on: Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for JS110 (XPO1 inhibitor) - kaiyun体育全站入口 //www.yitiaoweiba.com/en/%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9js110%ef%bc%88xpo1%e6%8a%91%e5%88%b6%e5%89%82%ef%bc%89%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%e7%94%b3%e8%af%b7%e8%8e%b7%e5%be%97%e7%be%8e%e5%9b%bdfda%e6%89%b9-2/ 创新疗法的发现、开发和商业化的生物制药公司。 Fri, 17 Mar 2023 06:50:29 +0000 hourly 1 https://wordpress.org/?v=6.7.2